Real-World Evidence Solutions Market Size, Share, Trends and Forecast, 2034
Real-World Evidence Solutions Market By Component (Dataset and Services), Therapeutic Area (Oncology, Cardiovascular, Neurology, Immunology, and Others), End-User (Healthcare Payers, Healthcare Providers, Pharmaceutical & Medical Devices Companies, and Other End Users), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 192 Report Code: ZMR-3365
Published Date: May-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.11 Billion | USD 8.17 Billion | 16.2% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Real-World Evidence Solutions Market, (2022 - 2028) (USD Billion)
- 2.2 Global Real-World Evidence Solutions Market : snapshot
- Chapter 3. Global Real-World Evidence Solutions Market - Industry Analysis
- 3.1 Real-World Evidence Solutions Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increase in backing from regulatory groups for the use of real-world evidence solutions to drive the market growth
- 3.3 Market Restraints
- 3.3.1. Lack of willingness to depend on real-world research to impede the market growth
- 3.4 Market Opportunities
- 3.4.1. Increasing emphasis on end-to-end real-world evidence services is likely to drive the market during the forecast period.
- 3.5 Market Challenges
- 3.5.1. Inadequate data processing infrastructure and broadly acknowledged methodological standards may pose challenges for the market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Component
- 3.7.2 Market attractiveness analysis By Therapeutic area
- 3.7.3 Market attractiveness analysis By End Users
- Chapter 4. Global Real-World Evidence Solutions Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Real-World Evidence Solutions Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Real-World Evidence Solutions Market - Component Analysis
- 5.1 Global Real-World Evidence Solutions Market overview: By Component
- 5.1.1 Global Real-World Evidence Solutions Market share, By Component, 2021 and 2028
- 5.2 Services
- 5.2.1 Global Real-World Evidence Solutions Market by Services, 2022 - 2028 (USD Billion)
- 5.3 Data Sets
- 5.3.1 Global Real-World Evidence Solutions Market by Data Sets, 2022 - 2028 (USD Billion)
- 5.1 Global Real-World Evidence Solutions Market overview: By Component
- Chapter 6. Global Real-World Evidence Solutions Market - Therapeutic area Analysis
- 6.1 Global Real-World Evidence Solutions Market overview: By Therapeutic area
- 6.1.1 Global Real-World Evidence Solutions Market share, By Therapeutic area, 2021 and 2028
- 6.2 Oncology
- 6.2.1 Global Real-World Evidence Solutions Market by Oncology, 2022 - 2028 (USD Billion)
- 6.3 Cardiovascular
- 6.3.1 Global Real-World Evidence Solutions Market by Cardiovascular, 2022 - 2028 (USD Billion)
- 6.4 Neurology
- 6.4.1 Global Real-World Evidence Solutions Market by Neurology, 2022 - 2028 (USD Billion)
- 6.5 Immunology
- 6.5.1 Global Real-World Evidence Solutions Market by Immunology, 2022 - 2028 (USD Billion)
- 6.6 Others
- 6.6.1 Global Real-World Evidence Solutions Market by Others, 2022 - 2028 (USD Billion)
- 6.1 Global Real-World Evidence Solutions Market overview: By Therapeutic area
- Chapter 7. Global Real-World Evidence Solutions Market - End Users Analysis
- 7.1 Global Real-World Evidence Solutions Market overview: By End Users
- 7.1.1 Global Real-World Evidence Solutions Market share, By End Users, 2021 and 2028
- 7.2 Pharmaceutical and Medical Devices Companies
- 7.2.1 Global Real-World Evidence Solutions Market by Pharmaceutical and Medical Devices Companies, 2022 - 2028 (USD Billion)
- 7.3 Healthcare Providers
- 7.3.1 Global Real-World Evidence Solutions Market by Healthcare Providers, 2022 - 2028 (USD Billion)
- 7.4 Other End Users
- 7.4.1 Global Real-World Evidence Solutions Market by Other End Users, 2022 - 2028 (USD Billion)
- 7.1 Global Real-World Evidence Solutions Market overview: By End Users
- Chapter 8. Real-World Evidence Solutions Market - Regional Analysis
- 8.1 Global Real-World Evidence Solutions Market Regional Overview
- 8.2 Global Real-World Evidence Solutions Market Share, by Region, 2021 & 2028 (USD Billion)
- 8.3. North America
- 8.3.1 North America Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.3.1.1 North America Real-World Evidence Solutions Market, by Country, 2022 - 2028 (USD Billion)
- 8.3.1 North America Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.4 North America Real-World Evidence Solutions Market, by Component, 2022 - 2028
- 8.4.1 North America Real-World Evidence Solutions Market, by Component, 2022 - 2028 (USD Billion)
- 8.5 North America Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028
- 8.5.1 North America Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028 (USD Billion)
- 8.6 North America Real-World Evidence Solutions Market, by End Users, 2022 - 2028
- 8.6.1 North America Real-World Evidence Solutions Market, by End Users, 2022 - 2028 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.4.2.1 Europe Real-World Evidence Solutions Market, by Country, 2022 - 2028 (USD Billion)
- 8.4.2 Europe Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.4 Europe Real-World Evidence Solutions Market, by Component, 2022 - 2028
- 8.4.1 Europe Real-World Evidence Solutions Market, by Component, 2022 - 2028 (USD Billion)
- 8.5 Europe Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028
- 8.5.1 Europe Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028 (USD Billion)
- 8.6 Europe Real-World Evidence Solutions Market, by End Users, 2022 - 2028
- 8.6.1 Europe Real-World Evidence Solutions Market, by End Users, 2022 - 2028 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.5.3.1 Asia Pacific Real-World Evidence Solutions Market, by Country, 2022 - 2028 (USD Billion)
- 8.5.3 Asia Pacific Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.4 Asia Pacific Real-World Evidence Solutions Market, by Component, 2022 - 2028
- 8.4.1 Asia Pacific Real-World Evidence Solutions Market, by Component, 2022 - 2028 (USD Billion)
- 8.5 Asia Pacific Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028
- 8.5.1 Asia Pacific Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028 (USD Billion)
- 8.6 Asia Pacific Real-World Evidence Solutions Market, by End Users, 2022 - 2028
- 8.6.1 Asia Pacific Real-World Evidence Solutions Market, by End Users, 2022 - 2028 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.6.4.1 Latin America Real-World Evidence Solutions Market, by Country, 2022 - 2028 (USD Billion)
- 8.6.4 Latin America Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.4 Latin America Real-World Evidence Solutions Market, by Component, 2022 - 2028
- 8.4.1 Latin America Real-World Evidence Solutions Market, by Component, 2022 - 2028 (USD Billion)
- 8.5 Latin America Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028
- 8.5.1 Latin America Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028 (USD Billion)
- 8.6 Latin America Real-World Evidence Solutions Market, by End Users, 2022 - 2028
- 8.6.1 Latin America Real-World Evidence Solutions Market, by End Users, 2022 - 2028 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Real-World Evidence Solutions Market, by Country, 2022 - 2028 (USD Billion)
- 8.7.5 The Middle-East and Africa Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 8.4 The Middle-East and Africa Real-World Evidence Solutions Market, by Component, 2022 - 2028
- 8.4.1 The Middle-East and Africa Real-World Evidence Solutions Market, by Component, 2022 - 2028 (USD Billion)
- 8.5 The Middle-East and Africa Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028
- 8.5.1 The Middle-East and Africa Real-World Evidence Solutions Market, by Therapeutic area, 2022 - 2028 (USD Billion)
- 8.6 The Middle-East and Africa Real-World Evidence Solutions Market, by End Users, 2022 - 2028
- 8.6.1 The Middle-East and Africa Real-World Evidence Solutions Market, by End Users, 2022 - 2028 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Optum Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 PPD LLC
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 PAREXEL International Corporation
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 ICON plc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 IBM Corporation
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 IQVIA
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Syneos Health Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 SAS Institute Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Oracle Corporation
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Cognizant Technology Solutions Corporation
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.1 Optum Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Real-World Evidence Solutions Market attractiveness, By Component
- 6. Global Real-World Evidence Solutions Market attractiveness, By Therapeutic area
- 7. Global Real-World Evidence Solutions Market attractiveness, By End Users
- 8. Global Real-World Evidence Solutions Market share by Component, 2022 and 2028 (USD Billion)
- 9. Global Real-World Evidence Solutions Market by Services, 2022 - 2028 (USD Billion)
- 10. Global Real-World Evidence Solutions Market by Data Sets, 2022 - 2028 (USD Billion)
- 11. Global Real-World Evidence Solutions Market share by Therapeutic area, 2022 and 2028 (USD Billion)
- 12. Global Real-World Evidence Solutions Market by Oncology, 2022 - 2028 (USD Billion)
- 13. Global Real-World Evidence Solutions Market by Cardiovascular, 2022 - 2028 (USD Billion)
- 14. Global Real-World Evidence Solutions Market by Neurology, 2022 - 2028 (USD Billion)
- 15. Global Real-World Evidence Solutions Market by Immunology, 2022 - 2028 (USD Billion)
- 16. Global Real-World Evidence Solutions Market by Others, 2022 - 2028 (USD Billion)
- 17. Global Real-World Evidence Solutions Market share by End Users, 2022 and 2028 (USD Billion)
- 18. Global Real-World Evidence Solutions Market by Pharmaceutical and Medical Devices Companies, 2022 - 2028 (USD Billion)
- 19. Global Real-World Evidence Solutions Market by Healthcare Providers, 2022 - 2028 (USD Billion)
- 20. Global Real-World Evidence Solutions Market by Other End Users, 2022 - 2028 (USD Billion)
- 21. Global Real-World Evidence Solutions Market share, by Region, 2022 and 2028
- 22. North America Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 23. Europe Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 24. Asia Pacific Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 25. Latin America Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
- 26. The Middle-East and Africa Real-World Evidence Solutions Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global Real-World Evidence Solutions Market: Snapshot
- 2. Drivers of the Real-World Evidence Solutions Market: impact analysis
- 3. North America Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 4. North America Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 5. North America Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 6. U.S. Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 7. U.S. Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 8. U.S. Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 9. Canada Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 10. Canada Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 11. Canada Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 12. Europe Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 13. Europe Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 14. Europe Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 15. Germany Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 16. Germany Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 17. Germany Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 18. France Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 19. France Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 20. France Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 21. U.K. Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 22. U.K. Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 23. U.K. Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 24. Italy Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 25. Italy Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 26. Italy Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 27. Spain Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 28. Spain Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 29. Spain Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 30. Rest of Europe Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 31. Rest of Europe Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 32. Rest of Europe Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 33. Asia Pacific Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 34. Asia Pacific Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 35. Asia Pacific Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 36. China Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 37. China Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 38. China Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 39. Japan Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 40. Japan Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 41. Japan Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 42. India Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 43. India Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 44. India Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 45. South Korea Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 46. South Korea Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 47. South Korea Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 48. South-East Asia Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 49. South-East Asia Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 50. South-East Asia Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 51. Rest of Asia Pacific Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 52. Rest of Asia Pacific Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 53. Rest of Asia Pacific Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 54. Latin America Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 55. Latin America Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 56. Latin America Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 57. Brazil Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 58. Brazil Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 59. Brazil Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 60. Mexico Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 61. Mexico Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 62. Mexico Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 63. Rest of Latin America Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 64. Rest of Latin America Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 65. Rest of Latin America Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 66. The Middle-East and Africa Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 67. The Middle-East and Africa Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 68. The Middle-East and Africa Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 69. GCC Countries Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 70. GCC Countries Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 71. GCC Countries Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 72. South Africa Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 73. South Africa Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 74. South Africa Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
- 75. Rest of Middle-East Africa Real-World Evidence Solutions Market revenue, By Component, 2022 - 2028 (USD Billion)
- 76. Rest of Middle-East Africa Real-World Evidence Solutions Market revenue, By Therapeutic area, 2022 - 2028 (USD Billion)
- 77. Rest of Middle-East Africa Real-World Evidence Solutions Market revenue, By End Users, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
The global real-world evidence solutions market is expected to grow due to increasing need for data-driven healthcare decision-making, the growing adoption of value-based care, and the rising demand for evidence to support drug development and regulatory approvals.
According to a study, the global real-world evidence solutions market size was worth around USD 2.11 Billion in 2024 and is expected to reach USD 8.17 Billion by 2034.
The global real-world evidence solutions market is expected to grow at a CAGR of 16.2% during the forecast period.
North America is expected to dominate the real-world evidence solutions market over the forecast period.
Leading players in the global real-world evidence solutions market include Optum Inc., PPD, LLC, PAREXEL International Corporation, ICON plc., IBM Corporation, IQVIA, Syneos Health Inc, SAS Institute Inc., Oracle Corporation, Cognizant Technology Solutions Corporation, among others.
The report explores crucial aspects of the real-world evidence solutions market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
